- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00473057
Study of Autologous Stem Cell Transplantation for Patients With Ischemic Stroke
Phase I Study of Autologous Bone Marrow Cell Transplantation in Patient With Ischemic Stroke
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Objective: The purpose of this study is to evaluate the safety and feasibility of intra-arterial and intravenous injection of autologous bone marrow mononuclear cells in patients in the acute and sub-acute phase (> 3 and < 90 days after symptoms onset) of ischemic cerebral infarct in the middle cerebral artery territory.
Methods: 15 patients with cerebral infarct within the middle cerebral artery territory will be enrolled in this prospective, nonrandomized, open-labeled study. Up to 10 patients will receive up to 500x 10 6 autologous bone marrow cells injected intra-arterially into the middle cerebral artery through percutaneous approach. The procedure is monitored by Transcranial Doppler (TCD) and electroencephalogram (EEG). Other 5 patients will receive up to 500x 10 6 autologous bone marrow cells injected intravenously. Changes in neurological deficits and improvements in functions will be evaluated at baseline and at regular intervals during follow-up ( 4 months). EEG and neuroimaging exams will be performed at baseline and at regular intervals during the follow-up period.
Study Type
Enrollment (Actual)
Phase
- Phase 1
Contacts and Locations
Study Locations
-
-
RJ
-
Rio de Janeiro, RJ, Brazil, 21.941-590
- Hospital Universitário Clementino Fraga Filho/UFRJ
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- clinical diagnosis of ischemic stroke lasting for more than 3 hours and less than 90 days from symptoms onset
- neuroimages exams showing ischemic cerebral infarct in the middle cerebral artery territory
- age between 18 and 75 years old
- NIHSS between 4 and 20
- spontaneous re-canalization of the middle cerebral artery documented by TCD or MRI
- signed informed consent
Exclusion Criteria:
- difficult in obtaining vascular access for percutaneous procedures
- vascular impossibility to reach the middle cerebral artery through percutaneous approach
- severe carotid stenosis( >70%, by Doppler) related to the severe stroke
- neurological worsening (>4 points in the NIHSS ) due to edema or intracerebral hemorrhage
- primary hematological disease
- neurodegenerative disorder
- previous stroke with mRS > 2
- intracardiac thrombosis
- auto-imune disorders
- osteopathies that could increase the risk of bone marrow harvesting procedure
- thrombophilias
- liver failure
- chronic renal failure (creatinine > 2mg/ml)
- life support dependence
- lacunar stroke
- pregnancy
- history of neoplasia or other comorbidity that could impact patient's short-term survival
- any condition that in the judgment of the investigator would place the patient under undue risk
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Absence of new neurological deficits during the procedure and/or in the 4 months follow-up.
Time Frame: 4 months
|
4 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Improvement of neurological deficits
Time Frame: 4 months
|
4 months
|
Improvement in the neuroimaging exams
Time Frame: 4 months
|
4 months
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Charles André, MD, PhD, Universidade Federal do Rio de Janeiro
- Principal Investigator: Gabriel R de Freitas, MD, PhD, Universidade Federal do Rio de Janeiro
- Principal Investigator: Rosalia Mendez-Otero, Md, PhD, Universidade Federal do Rio de Janeiro
- Principal Investigator: Lea Mirian Barbosa da Fonseca, MD, PhD, Universidade Federal do Rio de Janeiro
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Ischemia
- Pathologic Processes
- Necrosis
- Cardiovascular Diseases
- Vascular Diseases
- Cerebrovascular Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Brain Ischemia
- Stroke
- Brain Infarction
- Cerebral Arterial Diseases
- Intracranial Arterial Diseases
- Cerebral Infarction
- Infarction
- Ischemic Stroke
- Infarction, Middle Cerebral Artery
Other Study ID Numbers
- CONEP-10385
- CEP-HUCFF/UFRJ-169/03
- Proc.-CNPq-55.2201/2005-7
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Infarction, Middle Cerebral Artery
-
University of Roma La SapienzaNot yet recruitingMiddle Cerebral Artery Occlusion With Cerebral Infarction
-
Assistance Publique - Hôpitaux de ParisTerminatedMalignant Middle Cerebral Artery InfarctionFrance
-
National University of MalaysiaCytopeutics Sdn. Bhd.UnknownMiddle Cerebral Artery InfarctionMalaysia
-
University of MichiganCompletedStroke | Stroke, Chronic | Stroke, Middle Cerebral Artery With InfarctionUnited States
-
All India Institute of Medical Sciences, New DelhiPostgraduate Institute of Medical Education and Research; Sanjay Gandhi Postgraduate... and other collaboratorsCompletedMiddle Cerebral Artery Infarction | Anterior Cerebral Artery InfarctionIndia
-
Mahatma Gandhi Institute of Medical SciencesCompletedStroke, Middle Cerebral Artery With Infarction, Rehabilitation, Upper Limb Recovery, Economic BurdonIndia
-
Xuanwu Hospital, BeijingRecruitingInfarction, Middle Cerebral Artery | Symptomatic Chronic Middle Cerebral Artery OcclusionChina
-
UCB S.A. - Pharma SectorTerminatedAcute Ischaemic Middle Cerebral Artery StrokeSweden, Argentina, Austria, Belgium, France, Germany, Greece, Hungary, Italy, Norway, Poland, Singapore, Spain, Taiwan, Turkey
-
Ege UniversityCompletedCerebral HerniationTurkey
-
Celularity IncorporatedCelgene CorporationTerminatedStroke, Acute | Middle Cerebral Artery Stroke | Posterior Cerebral Artery StrokeUnited States
Clinical Trials on Autologous cell transplantation
-
Northwestern UniversityTerminated
-
Universidade Federal do Rio de JaneiroMinistry of Health, Brazil; National Research Council, Brazil; Ministry of Science...CompletedChronic and Accelerated SilicosisBrazil
-
Konstantinos TsimogiannisSuspendedFistula in Ano | Transsphincteric Anal FistulaSweden
-
Peking UniversityUnknown
-
Northwestern UniversityTerminated
-
Uppsala UniversityKarolinska University Hospital; Sahlgrenska University Hospital, Sweden; University... and other collaboratorsCompletedImpact of COVID-19 After Autologous Hematopoietic Stem Cell Transplantation in Sweden (AutoCOVID-19)Covid19 | Hematologic Neoplasms | Stem Cell Transplant Complications | Myeloma Multiple | Malignant LymphomaSweden
-
Federal Research Clinical Center of Federal Medical...Novagenesis Foundation; Ophiuchus Technologies AGUnknownSpinal Cord InjuryRussian Federation
-
Chaitanya Hospital, PuneUnknown
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States